Bristol Myers Squibb Co. (BMY)
51.21
+0.56
(+1.11%)
USD |
NYSE |
Dec 10, 16:00
51.50
+0.29
(+0.57%)
Pre-Market: 08:06
Bristol Myers Squibb Free Cash Flow: 15.30B for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amgen, Inc. | 11.54B |
| Gilead Sciences, Inc. | 9.162B |
| Johnson & Johnson | 20.46B |
| Eli Lilly & Co. | 6.436B |
| Regeneron Pharmaceuticals, Inc. | 3.881B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 6.311B |
| Cash from Investing (Quarterly) | -1.702B |
| Cash from Financing (Quarterly) | -1.49B |
| Free Cash Flow Per Share (Quarterly) | 2.938 |
| Free Cash Flow to Equity (Quarterly) | 5.879B |
| Free Cash Flow to Firm (Quarterly) | 6.329B |
| Free Cash Flow Yield | 14.66% |